Company profile for Rakuten Medical

NEW Drugs in Dev: 7
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Through technology, passion and determination, Rakuten Medical is pioneering the development of new approaches to treat cancer. We are a privately funded, global biotechnology company with offices in the U.S., Japan, Taiwan, the Netherlands and Germany. We aim to become a leader in precision-targeted therapies through our proprietary, anti-cancer treatment platform, Illuminox™. Illuminox is being studied to determine i...
Through technology, passion and determination, Rakuten Medical is pioneering the development of new approaches to treat cancer. We are a privately funded, global biotechnology company with offices in the U.S., Japan, Taiwan, the Netherlands and Germany. We aim to become a leader in precision-targeted therapies through our proprietary, anti-cancer treatment platform, Illuminox™. Illuminox is being studied to determine if it acts broadly across different tumor types and patient populations by potentially inducing tumor necrosis with minimal effects on normal tissue while triggering an immune response for enhanced anti-cancer activity.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
900 Concar Dr Suite 400 San Mateo, CA 9440
Telephone
Telephone
858-925-5619
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/rakuten-medical-and-lotte-biologics-sign-manufacturing-agreement-to-support-biopharmaceuticals-in-global-oncology-program-302660362.html

PR NEWSWIRE
13 Jan 2026

https://www.fiercebiotech.com/biotech/rakuten-lights-path-2028-fda-filing-fresh-100m-raise

FIERCE BIOTECH
07 Jan 2026

https://www.prnewswire.com/news-releases/rakuten-medical-to-host-rd-day-highlighting-recent-interim-data-from-phase-1b2-clinical-trial-of-asp-1929-photoimmunotherapy-in-combination-with-anti-pd-1-in-rm-hnscc-302158077.html

PR NEWSWIRE
30 May 2024
ASCO 2024: Rakuten’s photoimmunotherapy & Keytruda combo shows efficacy in HNSCC
ASCO 2024: Rakuten’s photoimmunotherapy & Keytruda combo shows efficacy in HNSCC

28 May 2024

// Phalguni Deswal PHARMACEUTICAL TECHNOLOGY

https://www.pharmaceutical-technology.com/news/asco-2024-rakutens-photoimmunotherapy-and-keytruda-combo-shows-efficacy-in-hnscc/

Phalguni Deswal PHARMACEUTICAL TECHNOLOGY
28 May 2024

https://www.prnewswire.com/news-releases/rakuten-medicals-poster-presentation-at-aacr-2024-demonstrates-reduction-in-photoimmunotherapy-induced-edema-in-mice-with-cox-2-inhibition-302114857.html

PR NEWSWIRE
11 Apr 2024

https://www.prnewswire.com/news-releases/rakuten-medical-and-hikma-sign-exclusive-licensing-agreement-for-alluminox-platform-cancer-treatment-in-the-middle-east-and-north-africa-301897871.html

PR NEWSWIRE
10 Aug 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty